All News

The summer months can be a time of increased activity for many people, as warmer temperatures usher in numerous outdoor events that can be more strenuous and bring us closer to nature.

Glycopyrrolate bromide is a quick-onset long-acting muscarinic antagonist bronchodilator with FDA approval for use as maintenance treatment of COPD. Seebri Neohaler is approved for use at a dose of 15.6 ug inhaled twice daily.

There is a growing group of LAMA/LABA combination therapies in development. Investigations into the risks and benefits of LAMA/LABA therapy have demonstrated benefits.

Five pharmacies from four states have filed a class-action lawsuit against pharmacy benefit manager Express Scripts.

How do independent pharmacies survive? The best way to find out is to ask them.

A group of California pharmacists has sued CVS Health, accusing the retail giant of unfair business practices.

In one of the largest opioid diversion schemes to be uncovered in New York, a former pharmacy owner and her husband have pled guilty to several charges related to a multimillion-dollar oxycodone distribution scheme.

A new analysis found that Americans are misusing drugs–both illicit and prescribed drugs– at an alarming rate.

Medication reconciliation programs for patients discharged from hospitals reduced the risk of hospital readmission by 50% and helped avoid unnecessary health care costs, according to a new study.

So far, not many pharmacists are taking advantage of the opportunity.

Earlier this month, the U.S. Department of Justice announced that Rodney Dalton Logan, 63, of Muscle Shoals, Ala. agreed to plead guilty to obstructing a Medicare audit in 2012.

New branded drugs, new generics

New OTC products for eyes and ears.

There are so many opportunities for pharmacists out there. Technology can help uncover them, and we can follow them to a fulfilling career.

Medicare should have the same authority that Medicaid has to negotiate drug prices directly with manufacturers. If the government can do it for one program, it can do it for another.

CLIA-waived tests may be the next big thing.

Epinephrine saves lives. So does naloxone. Why are they regarded differently?

Pharmacists are the most accessible healthcare resource. Once trained in naloxone use, we can train our patients in all aspects of opioid use. This will make a difference.

"Naloxone should be the fire extinguisher in the home of everyone who is at risk."

A new campaign is warning seniors about the risk of buying drugs from illegal online pharmacies.

When a snap decision is called for, “What is our corporate loss-prevention policy?” can compete in an employee’s brain with “What is the best thing for the patient?”

With the industry changing from a pill-centered model to a patient-centered model, med sync becomes more important than ever.

Healthcare has changed, and the emphasis on transitions of care has grown as inpatient and outpatient services are linking up.

A champion of pain patients and a proponent of limited opioid access talk about the issues in a genial debate.

The rules vary from state to state. Pharmacists need to stay informed.

The Pew Charitable Trusts took a look at antibiotic stewardship programs in 10 U.S. health systems. Here's the result.

There are more ways than one to run a specialty pharmacy - and success can be found with any of them.

Lonsurf is a new, orally administered cytotoxic drug for the treatment of patients with metastatic colorectal cancer.